CRVO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Cervomed Inc (CRVO).


$19.31M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

CRVO Market Cap. (MRY)


CRVO Shares Outstanding (MRY)


CRVO Assets (MRY)


Total Assets

$43.08M

Total Liabilities

$3.88M

Total Investments

$29.92M

CRVO Income (MRY)


Revenue

$9.74M

Net Income

-$16.29M

Operating Expense

$27.97M

CRVO Cash Flow (MRY)


CF Operations

-$16.53M

CF Investing

-$28.66M

CF Financing

$46.40M

CRVO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CRVO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$43,081,610 (332.00%)

$9,972,521 (139.86%)

$4,157,706 (-89.01%)

$37,839,151 (36.46%)

Assets Current

$43,081,610 (332.34%)

$9,964,751 (139.67%)

$4,157,706 (-89.01%)

$37,823,573 (101.44%)

Assets Non-Current

$0 (0%)

$7,770 (0%)

$0 (0%)

$15,578 (-99.83%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$39,202,328 (431.43%)

$7,376,774 (122.16%)

-$33,285,059 (-195.34%)

$34,911,467 (40.69%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$8,999,496 (15.48%)

$7,792,846 (90.37%)

$4,093,579 (-89.03%)

$37,313,558 (101.53%)

Accumulated Other Comprehensive Income

$56,197 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$29,922,523 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$29,922,523 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,254,231 (146.26%)

$915,404 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,511,440 (128.15%)

$662,471 (580.84%)

$97,302 (-89.73%)

$947,495 (73.58%)

Accumulated Retained Earnings (Deficit)

-$70,731,484 (-29.92%)

-$54,440,789 (-4.16%)

-$52,268,916 (59.79%)

-$130,005,111 (-22.75%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$12,414,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$12,414,000 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$3,879,282 (49.45%)

$2,595,747 (-80.27%)

$13,155,554 (349.35%)

$2,927,684 (0.42%)

Liabilities Current

$3,879,282 (49.45%)

$2,595,747 (-80.27%)

$13,155,554 (349.35%)

$2,927,684 (20.19%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

CRVO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,737,974 (36.29%)

$7,144,872 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,166,762 (40.61%)

$6,519,268 (-25.37%)

$8,735,015 (17.32%)

$7,445,277 (15.54%)

Research & Development Expense

$18,798,343 (122.77%)

$8,438,499 (16.60%)

$7,237,165 (-14.85%)

$8,499,414 (-9.85%)

Operating Expenses

$27,965,105 (86.96%)

$14,957,767 (-6.35%)

$15,972,180 (-35.28%)

$24,677,107 (54.47%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

-$443,893 (73.50%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (35.29%)

-$24,095,727 (-69.86%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (35.29%)

-$24,095,727 (-69.86%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (35.29%)

-$24,095,727 (-49.33%)

Weighted Average Shares

$8,073,155 (203.34%)

$2,661,416 (95.80%)

$1,359,261 (4.73%)

$1,297,906 (80.83%)

Weighted Average Shares Diluted

$8,073,155 (203.34%)

$2,661,416 (95.80%)

$1,359,261 (4.73%)

$1,297,906 (80.83%)

Earning Before Interest & Taxes (EBIT)

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (36.46%)

-$24,539,620 (-54.72%)

Gross Profit

$9,737,974 (36.29%)

$7,144,872 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$18,227,131 (-133.30%)

-$7,812,895 (51.08%)

-$15,972,180 (35.28%)

-$24,677,107 (-54.47%)

CRVO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$28,661,129 (0%)

$0 (0%)

-$12,235,738 (-305993.45%)

$4,000 (0%)

Net Cash Flow from Financing

$46,398,606 (316.16%)

$11,149,114 (222882.28%)

$5,000 (-99.98%)

$33,295,752 (86.10%)

Net Cash Flow from Operations

-$16,530,827 (-121.89%)

-$7,449,847 (50.23%)

-$14,969,114 (-3.22%)

-$14,501,789 (-7.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,206,650 (-67.38%)

$3,699,267 (113.60%)

-$27,199,852 (-244.70%)

$18,797,963 (333.31%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$28,661,129 (0%)

$0 (0%)

-$12,235,738 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$4,000 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$46,398,606 (265.41%)

$12,697,757 (0%)

$0 (0%)

$33,295,752 (76.42%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,405,722 (244.85%)

$407,632 (-56.08%)

$928,052 (3.43%)

$897,260 (21.89%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$93,416 (-9.45%)

CRVO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

-

Profit Margin

-167.30% (-450.33%)

-30.40%

-

-

EBITDA Margin

-167.30% (-450.33%)

-30.40%

-

-

Return on Average Equity (ROAE)

-46.50% (-154.10%)

-18.30% (85.90%)

-129.80% (-138.17%)

-54.50% (11.95%)

Return on Average Assets (ROAA)

-42.50% (-174.19%)

-15.50% (76.83%)

-66.90% (-30.16%)

-51.40% (7.05%)

Return on Sales (ROS)

-167.30% (-450.33%)

-30.40%

-

-

Return on Invested Capital (ROIC)

-60.90% (-102.83%)

2155.30% (2112.42%)

-107.10% (-107.45%)

1436.80% (-51.90%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.16 (87.56%)

-9.3 (-1307.72%)

-0.66 (46.35%)

-1.23 (53.51%)

Price to Sales Ratio (P/S)

1.94 (-31.74%)

2.84

-

-

Price to Book Ratio (P/B)

0.49 (-91.60%)

5.87 (1993.23%)

-0.31 (-134.83%)

0.89 (-56.61%)

Debt to Equity Ratio (D/E)

0.1 (-71.88%)

0.35 (189.11%)

-0.4 (-570.24%)

0.08 (-28.21%)

Earnings Per Share (EPS)

-2.02 (-146.34%)

-0.82 (92.85%)

-11.47 (38.21%)

-18.57 (17.47%)

Sales Per Share (SPS)

1.21 (-55.08%)

2.69 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.05 (26.83%)

-2.8 (74.58%)

-11.01 (1.41%)

-11.17 (40.84%)

Book Value Per Share (BVPS)

4.86 (75.18%)

2.77 (111.32%)

-24.49 (-191.04%)

26.9 (-22.20%)

Tangible Assets Book Value Per Share (TABVPS)

5.34 (42.41%)

3.75 (22.49%)

3.06 (-89.51%)

29.15 (9.61%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (93.33%)

-15 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.71 (95.31%)

-15.13 (-6232.64%)

-0.24 (-163.56%)

0.38 (120.32%)

Asset Turnover

0.25 (-50.10%)

0.51 (0%)

0 (0%)

0 (0%)

Current Ratio

11.11 (189.29%)

3.84 (1114.87%)

0.32 (-97.55%)

12.92 (67.58%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$16,530,827 (-121.89%)

-$7,449,847 (50.23%)

-$14,969,114 (-3.25%)

-$14,497,789 (-6.97%)

Enterprise Value (EV)

$11,570,087 (-64.80%)

$32,871,913 (781.98%)

$3,727,052 (140.59%)

-$9,181,459 (-131.49%)

Earnings Before Tax (EBT)

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (36.46%)

-$24,539,620 (-54.72%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$16,290,695 (-650.08%)

-$2,171,873 (86.07%)

-$15,591,428 (36.22%)

-$24,446,204 (-55.14%)

Invested Capital

$30,202,832 (7359.04%)

-$416,072 (38.58%)

-$677,427 (71.80%)

-$2,402,091 (-40.34%)

Working Capital

$39,202,328 (431.99%)

$7,369,004 (181.90%)

-$8,997,848 (-125.78%)

$34,895,889 (113.55%)

Tangible Asset Value

$43,081,610 (332.00%)

$9,972,521 (139.86%)

$4,157,706 (-89.01%)

$37,839,151 (98.21%)

Market Capitalization

$19,313,754 (-55.39%)

$43,296,588 (319.78%)

$10,314,070 (-66.82%)

$31,085,700 (-38.92%)

Average Equity

$35,038,279 (195.31%)

$11,864,892 (-1.24%)

$12,013,608 (-72.83%)

$44,214,241 (69.54%)

Average Assets

$38,288,394 (172.95%)

$14,027,472 (-39.82%)

$23,309,676 (-50.31%)

$46,910,957 (60.80%)

Invested Capital Average

$26,757,891 (26653.17%)

-$100,771 (-100.69%)

$14,559,248 (952.44%)

-$1,707,940 (-221.68%)

Shares

8,253,741 (45.45%)

5,674,520 (317.36%)

1,359,628 (0.05%)

1,358,938 (59.21%)